-
Mashup Score: 2Pain - 6 day(s) ago
Pain is an unpleasant sensory and emotional experience. No two people feel pain the same way, even if the reasons for their pain are alike. Pain is a highly personal experience and a person’s report of their own pain is the best measure. Pain can feel mild or severe. Pain can include pricking, tingling, stinging, burning, shooting, aching, or electric sensations.
Source: www.ninds.nih.govCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0NINDS at Neuroscience 2024 - 2 month(s) ago
Learn about NINDS staff presentations at the 2024 Neuroscience meeting in Chicago, IL, get info on connecting with program directors, and access resources tailored for meeting attendees.
Source: www.ninds.nih.govCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 4Ataxia and Cerebellar or Spinocerebellar Degeneration - 2 month(s) ago
Ataxia often occurs when parts of the nervous system that control movement are damaged. People with ataxia experience a failure of muscle control in their arms and legs, resulting in a lack of balance and coordination or a disturbance of gait. The phrases cerebellar degeneration and spinocerebellar degeneration are used to describe changes that have taken place in a person’s nervous system; neither term constitutes a specific diagnosis.
Source: www.ninds.nih.govCategories: General Medicine News, General HCPsTweet-
Ataxia often occurs when parts of the nervous system that control movement are damaged. Most disorders that result in ataxia cause cells in the part of the brain called the cerebellum to degenerate, or atrophy. Learn more https://t.co/bXjQYpHbpS Via @NIH_NINDS #AtaxiaAwarenessDay https://t.co/thvFuSgX1A
-
-
Mashup Score: 2Updates on ACT for ALS - 2 month(s) ago
Amyotrophic Lateral Sclerosis, or ALS, is a progressive and fatal neurodegenerative disease, affecting around 30,000 people in the United States. Through the Accelerating Access to Critical Therapies for ALS Act (ACT for ALS) and beyond, we at NINDS have joined the fight against the relentless ALS clock, and we are working every day to try to slow it down, and hopefully someday, eliminate it completely.
Source: www.ninds.nih.govCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 2Updates on ACT for ALS - 2 month(s) ago
Amyotrophic Lateral Sclerosis, or ALS, is a progressive and fatal neurodegenerative disease, affecting around 30,000 people in the United States. Through the Accelerating Access to Critical Therapies for ALS Act (ACT for ALS) and beyond, we at NINDS have joined the fight against the relentless ALS clock, and we are working every day to try to slow it down, and hopefully someday, eliminate it completely.
Source: www.ninds.nih.govCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 5Join us at the 2024 NINDS Nonprofit Forum! - 4 month(s) ago
On July 23-24, NINDS will host its 2024 Nonprofit Forum, which brings together the neuroscience community, including nonprofit and patient advocacy organizations, professional societies focused on neurological disorders and neuroscience research, people with lived experience of neurological disorders, NINDS staff, researchers, academia, and other federal partners, to build connections, learn from one another, and continue to make progress together.
Source: www.ninds.nih.govCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 6Request for Information: Soliciting Input on Opportunities, Gaps, and Challenges in Global Health Research in Neurological Diseases and Stroke - 5 month(s) ago
Purpose This time-sensitive Request for Information (RFI) seeks input on the most important knowledge gaps, health research needs, and promising opportunities to guide global health activities in neurological diseases and disorders, particularly in respect to research in Low- and Middle-Income Countries (LMICs) and mutually beneficial partnerships between LMICs and High-income Countries (HICs).
Source: www.ninds.nih.govCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 2NINDS at AAN 2024 Annual Meeting - 8 month(s) ago
Join NINDS at the American Academy of Neurology Annual Meeting! NINDS is excited to have booth #1016 at the American Academy of Neurology (AAN) Annual Meeting in Denver April 13-18, 2024. If you’re attending the meeting, read below to learn how to connect with us in Denver and browse the resources to learn more about our Institute and the training, funding, and educational resources available. This year, during NIH Day on Tuesday, April 16, we’ll be hosting Coffee Connects with several NINDS staff.
Source: www.ninds.nih.govCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 4OPEN Stage Webinar: Support for Research on the Epilepsies - 8 month(s) agoSource: www.ninds.nih.govCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 4OPEN Stage Webinar: Support for Research on the Epilepsies - 9 month(s) agoSource: www.ninds.nih.govCategories: General Medicine News, NeurologyTweet
There’s a lot of science on DPN—and also plenty of myths. This #KNOWvember, let’s get to #knowDPN by exploring both. Learn what’s fact and what’s fiction about #diabeticperipheralneuropathy, and get closer to the truth. Read more: https://t.co/xweXxDTWPo #DiabetesAwareness https://t.co/KgKEmF1rti